⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 12, 2019Arthritis Research & TherapyOpen Access

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy

François Vercruysse Thomas Barnetche Estibaliz Lazaro Émilie Shipley François Lifermann Alexandre Balageas X. Delbrel Bruno Fautrel Christophe Richez Thierry Schaeverbeke Marie‐Elise Truchetet

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

This study highlights the therapeutic implications of the phenotypic dichotomy of AOSD and should help us better codify AOSD treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vercruysse et al. (2019) studied this question.

synapsesocial.com/papers/69d8b17b17a1cc0598d17d7b https://doi.org/10.1186/s13075-019-1838-6

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Adult-onset Still's diseasePrognostic Study · 2014 · 523 citations
2Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular diseaseOriginal Research · 2001 · 169 citations
3Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesisCase-Control Study · 2010 · 255 citations
4Clinical Manifestations of Adult‐Onset Still's Disease Presenting With Erosive Arthritis: Association With Low Levels of Ferritin and Interleukin‐18Retrospective Study · 2013 · 85 citations
5Adult-Onset Still’s Disease: From Pathophysiology to Targeted TherapiesOriginal Research · 2012 · 66 citations

Adult Onset Still's Disease and Autoinflammation2012
Biological therapy of traditional therapy-resistant adult-onset Still&rsquo;s disease: an evidence-based review2018
Tocilizumab Improved both Clinical and Laboratory Manifestations Except for Interleukin-18 in a Case of Multiple Drug-Resistant Adult-Onset Still's Disease2011
Endothelial-derived FABP4 promotes EGFR activation in fibroblast-like synoviocytes during osteoarthritis synovial ferroptosisArthritis Research & Therapy · 2026
Plexin C1 promotes synovial aggression and inflammation through STAT3-dependent Cyclin D1 activation in rheumatoid arthritisArthritis Research & Therapy · 2026

More from Arthritis Research & Therapy

More from Centre Hospitalier Universitaire de Bordeaux

More from Centre Hospitalier De Pau

More from Centre Hospitalier de Dax –Côte d’Argent